680: What blood gas parameters can make you suspect methemoglobinemia?
679: The problem with hypo-osmolar solutions in neurological patients
678: The rare case when a very hypotonic solution may be indicated
677: Is there an efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease?
676: Are standard doses of apixaban as effective as warfarin in severe obesity?
675: How to judge whether a journal is reputable?
674: Why 3 days of outpatient remdesivir is probably not going to catch on
673: Is this a better metric for antibiotic stewardship?
672: Is there finally a clinically relevant reason to choose ketamine over etomidate for RSI?
671: What predicts critical care pharmacist intervention – patient acuity or medication regimen complexity?
670: How to answer a question like an experienced pharmacist, even if you’re brand new
- « Previous Page
- 1
- …
- 30
- 31
- 32
- 33
- 34
- …
- 88
- Next Page »